Sort by
Items per page

Send to

Choose Destination

Best matches for cannabidiol and cancer:

Cannabidiol Claims and Misconceptions. Russo EB et al. Trends Pharmacol Sci. (2017)

Cannabidiol: State of the art and new challenges for therapeutic applications. Pisanti S et al. Pharmacol Ther. (2017)

Cannabinoids for Symptom Management and Cancer Therapy: The Evidence. Davis MP et al. J Natl Compr Canc Netw. (2016)

Search results

Items: 1 to 20 of 217


Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells.

Ivanov VN, Wu J, Wang TJC, Hei TK.

Oncotarget. 2019 Jan 25;10(8):825-846. doi: 10.18632/oncotarget.26582. eCollection 2019 Jan 25.


The Potential Clinical Implications and Importance of Drug Interactions Between Anticancer Agents and Cannabidiol in Patients With Cancer.

Opitz BJ, Ostroff ML, Whitman AC.

J Pharm Pract. 2019 Feb 18:897190019828920. doi: 10.1177/0897190019828920. [Epub ahead of print]


Development of a validated method for the qualitative and quantitative analysis of cannabinoids in plant biomass and medicinal cannabis resin extracts obtained by super-critical fluid extraction.

Elkins AC, Deseo MA, Rochfort S, Ezernieks V, Spangenberg G.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 30;1109:76-83. doi: 10.1016/j.jchromb.2019.01.027. [Epub ahead of print]


An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine.

Urits I, Borchart M, Hasegawa M, Kochanski J, Orhurhu V, Viswanath O.

Pain Ther. 2019 Feb 5. doi: 10.1007/s40122-019-0114-4. [Epub ahead of print] Review.


New Prospect for Cancer Cachexia: Medical Cannabinoid.

Wang J, Wang Y, Tong M, Pan H, Li D.

J Cancer. 2019 Jan 1;10(3):716-720. doi: 10.7150/jca.28246. eCollection 2019. Review.


Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol.

Dall'Stella PB, Docema MFL, Maldaun MVC, Feher O, Lancellotti CLP.

Front Oncol. 2019 Jan 18;8:643. doi: 10.3389/fonc.2018.00643. eCollection 2018.


Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells.

Alharris E, Singh NP, Nagarkatti PS, Nagarkatti M.

Oncotarget. 2019 Jan 1;10(1):45-59. doi: 10.18632/oncotarget.26534. eCollection 2019 Jan 1.


Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer.

Sharafi G, He H, Nikfarjam M.

J Pancreat Cancer. 2019 Jan 25;5(1):1-7. doi: 10.1089/pancan.2018.0019. eCollection 2019. Review.


Cannabinoids as a Potential New and Novel Treatment for Melanoma: A Pilot Study in a Murine Model.

Simmerman E, Qin X, Yu JC, Baban B.

J Surg Res. 2019 Mar;235:210-215. doi: 10.1016/j.jss.2018.08.055. Epub 2018 Oct 30.


Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies.

Taha T, Meiri D, Talhamy S, Wollner M, Peer A, Bar-Sela G.

Oncologist. 2019 Jan 22. pii: theoncologist.2018-0383. doi: 10.1634/theoncologist.2018-0383. [Epub ahead of print]


Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells.

Jeong S, Yun HK, Jeong YA, Jo MJ, Kang SH, Kim JL, Kim DY, Park SH, Kim BR, Na YJ, Lee SI, Kim HD, Kim DH, Oh SC, Lee DH.

Cancer Lett. 2019 Apr 10;447:12-23. doi: 10.1016/j.canlet.2019.01.011. Epub 2019 Jan 18.


Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer.

Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L.

Biomed Res Int. 2018 Dec 4;2018:1691428. doi: 10.1155/2018/1691428. eCollection 2018. Review.


Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells.

Kosgodage US, Uysal-Onganer P, MacLatchy A, Mould R, Nunn AV, Guy GW, Kraev I, Chatterton NP, Thomas EL, Inal JM, Bell JD, Lange S.

Transl Oncol. 2019 Mar;12(3):513-522. doi: 10.1016/j.tranon.2018.12.004. Epub 2018 Dec 28.


Medical Use of Cannabinoids.

Fraguas-Sánchez AI, Torres-Suárez AI.

Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1. Review.


Up-regulation of heme oxygenase-1 expression and inhibition of disease-associated features by cannabidiol in vascular smooth muscle cells.

Schwartz M, Böckmann S, Hinz B.

Oncotarget. 2018 Oct 2;9(77):34595-34616. doi: 10.18632/oncotarget.26191. eCollection 2018 Oct 2.


Low doses of widely consumed cannabinoids (cannabidiol and cannabidivarin) cause DNA damage and chromosomal aberrations in human-derived cells.

Russo C, Ferk F, Mišík M, Ropek N, Nersesyan A, Mejri D, Holzmann K, Lavorgna M, Isidori M, Knasmüller S.

Arch Toxicol. 2019 Jan;93(1):179-188. doi: 10.1007/s00204-018-2322-9. Epub 2018 Oct 19.


Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol.

Kenyon J, Liu W, Dalgleish A.

Anticancer Res. 2018 Oct;38(10):5831-5835. doi: 10.21873/anticanres.12924.


Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.

Rodríguez-Muñoz M, Onetti Y, Cortés-Montero E, Garzón J, Sánchez-Blázquez P.

Mol Brain. 2018 Sep 17;11(1):51. doi: 10.1186/s13041-018-0395-2.


Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).

Mersiades AJ, Tognela A, Haber PS, Stockler M, Lintzeris N, Simes J, McGregor I, Olver I, Allsop DJ, Gedye C, Kirby AC, Morton RL, Fox P, Clarke S, Briscoe K, Aghmesheh M, Wong N, Walsh A, Hahn C, Grimison P.

BMJ Open. 2018 Sep 12;8(9):e020745. doi: 10.1136/bmjopen-2017-020745.


Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.

López-Valero I, Saiz-Ladera C, Torres S, Hernández-Tiedra S, García-Taboada E, Rodríguez-Fornés F, Barba M, Dávila D, Salvador-Tormo N, Guzmán M, Sepúlveda JM, Sánchez-Gómez P, Lorente M, Velasco G.

Biochem Pharmacol. 2018 Nov;157:266-274. doi: 10.1016/j.bcp.2018.09.007. Epub 2018 Sep 7.

Supplemental Content

Loading ...
Support Center